Cholesteryl Ester Transfer Protein Inhibition: A Double-Edged Sword in Cardiovascular Health and Age-Related Macular Degeneration Risk

Cholesteryl Ester Transfer Protein Inhibition: A Double-Edged Sword in Cardiovascular Health and Age-Related Macular Degeneration Risk

Genetic analyses reveal that cholesteryl ester transfer protein (CETP) inhibition, while beneficial for cardiovascular disease, is associated with an increased risk of age-related macular degeneration (AMD) across European and East Asian populations, highlighting a critical safety concern.